semaglutide nature medicine Proteomic changes upon treatment with in individuals with obesity Oral GLP-1 Medication Helps Patients
Description
Retatrutide is a synthetic 39-amino acid peptide and triple agonist of the glucagon-like peptide-1 (GLP-1) receptor, glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon receptor

The Wisconsin Better Business Bureau is warning consumers about a wave of weight loss scams targeting people looking for popular weight loss medications.

Read Serena Williams Opens Up About Using a GLP-1 to Support Weight Loss Postpartum on NewBeauty Expert beauty insights, trends, and treatments across skincare and aesthetics to help you look and feel your best.

When activated, these receptors appear to dampen the dopamine-driven reward response that makes alcohol feel pleasurable and reinforcing effectively quieting the neurological "pull" toward drinking

These medications exert (in)direct hepatic actions by reducing steatosis, attenuating inflammation, and potentially reversing fibrosis, while simultaneously addressing systemic metabolic abnormalities including excessive obesity, insulin resistance, and cardiovascular risk
